Treating High Grade Serous Ovarian Cancer and Triple Negative Breast Cancer

Oncology Round Table Meet- MumbaiПодробнее

A Webinar on PARP Inhibitors in Epithelial Ovarian CancerПодробнее

Comprehensive HRR Panel over a BRCA 1/2 testing, What works best for PARP inhibitors?Подробнее

Treatment of Low Grade Serous Ovarian Cancer: One size doesn't fit allПодробнее

Masterclass in Ovarian & Endometrial Cancer - 17 Sept - 6 PMПодробнее

WCRC 2022 Final PresentationПодробнее

Choice of Cancer Screening TestsПодробнее

IASO Masterclass- Hereditary Breast CancerПодробнее

High Grade Serous Ovarian Cancer simplifiedПодробнее

07/11/2022 - New Horizons in the Therapy of Gynecologic CancerПодробнее

Webinar: Genetics and Ovarian Cancer (Full)Подробнее

PARP Inhibitors For The Treatment & Prevention Of Hereditary Breast & Ovarian CancerПодробнее

Drs. Monk, Moore, & Pepin discuss #OvarianCancer updates from #SGOMtg - https://bit.ly/367EGnOПодробнее

Ovarian cancerПодробнее

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel ApproachesПодробнее

Ovarian Cancer Symposium 2021: Session 4 PARP InhibitorsПодробнее

What is HRD (Homologous Recombination Deficiency) and how does it impact ovarian cancer?Подробнее

AOGD Webinar on Ovarian And Breast Cancer ConclaveПодробнее

Beyond the Stories – Advancements in Hereditary Cancer ResearchПодробнее

ovarian cancer 2021: Recent advance in treatmentПодробнее